Good Health Can’t Wait.

More documents

Recommendations

Info

Good Health Can’t Wait. Dr. Reddy’s Laboratories Limited EXTRACT OF IFRS CONSOLIDATED FINANCIAL STATEMENTS We have adopted IFRS as issued by International Accounting Standards Board (IASB) for preparing our financial statements for the purpose of filings with SEC. We have furnished all our interim financial reports of fiscal 2015 with SEC which were prepared under IFRS. The Annual Report in Form 20-F, when filed with the SEC, will also be made available at the Company’s website. A hard copy of such Annual Report in Form 20-F will be made available to the shareholders, free of charge, upon request. For details visit www.drreddys.com. The extract of the consolidated financial statements prepared under IFRS has been provided here under. CONSOLIDATED STATEMENT OF FINANCIAL POSITION PARTICULARS ALL AMOUNTS IN INDIAN RUPEES MILLIONS, EXCEPT SHARE DATA AND PER SHARE DATA AS OF 31 MARCH 2015 AS OF 31 MARCH 2014 ASSETS Current assets Cash and cash equivalents 5,394 8,451 Other investments 34,259 25,083 Trade and other receivables 40,755 33,037 Inventories 25,529 23,992 Derivative financial instruments 800 554 Current tax assets 1,819 1,298 Other current assets 11,282 11,332 Total current assets 119,838 103,747 Non-current assets Property, plant and equipment 48,090 44,424 Goodwill 3,380 3,428 Other intangible assets 13,050 11,269 Investment in equity accounted investees 1,033 806 Other investments – non-current 2,817 0 Deferred tax assets 5,792 6,054 Other non-current assets 762 495 Total non-current assets 74,924 66,476 Total assets 194,762 170,223 LIABILITIES AND EQUITY Current liabilities Trade and other payables 10,660 10,503 Derivative financial instruments 462 305 Current tax liabilities 2,506 1,192 Short-term borrowings 21,857 20,607 Long-term borrowings, current portion 6,962 3,395 Provisions 4,231 2,819 Other current liabilities 17,317 15,242 Total current liabilities 63,995 54,063 Non-current liabilities Long-term borrowings, excluding current portion 14,307 20,740 Provisions – non-current 53 92 Deferred tax liabilities 1,779 2,744 Other non-current liabilities 3,326 1,783 Total non-current liabilities 19,465 25,359 Total liabilities 83,460 79,422 Equity Share capital 852 851 Equity shares held by controlled trust - (5) Share premium 22,178 21,553 Share based payment reserve 1,081 1,008 Retained earnings 83,643 65,051 Other components of equity 3,548 2,343 Total equity 111,302 90,801 Total liabilities and equity 194,762 170,223 222
Consolidated Financial Statements Annual Report 2014 - 15 CONSOLIDATED INCOME STATEMENT PARTICULARS ALL AMOUNTS IN INDIAN RUPEES MILLIONS, EXCEPT SHARE DATA AND PER SHARE DATA FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 FOR THE YEAR ENDED 31 MARCH 2013 Revenues 148,189 132,170 116,266 Cost of revenues 62,786 56,369 55,687 Gross profit 85,403 75,801 60,579 Selling, general and administrative expenses 42,585 38,783 34,272 Research and development expenses 17,449 12,402 7,674 Other (income)/expense, net (917) (1,416) (2,479) Total operating expenses 59,117 49,769 39,467 Results from operating activities 26,286 26,032 21,112 Finance income 2,774 1,674 1,478 Finance expense (1,092) (1,274) (1,018) Finance (expense)/ income, net 1,682 400 460 Share of profit of equity accounted investees, net of tax 195 174 104 Profit before tax 28,163 26,606 21,676 Tax expense (5,984) (5,094) (4,900) Profit for the year 22,179 21,512 16,776 Attributable to: Equity holders of the Company 22,179 21,515 16,777 Non-controlling interest - (3) (1) Profit for the year 22,179 21,512 16,776 Earnings per share: Basic earnings per share of `5/- each 130.22 126.52 98.82 Diluted earnings per share of `5/- each 129.75 126.04 98.44 Weighted average number of equity shares used in computing earnings per equity share: Basic 170,314,506 170,044,518 169,777,458 Diluted 170,933,433 170,695,017 170,432,680 CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME PARTICULARS ALL AMOUNTS IN INDIAN RUPEES MILLIONS, EXCEPT SHARE DATA AND PER SHARE DATA FOR THE YEAR ENDED 31 MARCH 2015 FOR THE YEAR ENDED 31 MARCH 2014 FOR THE YEAR ENDED 31 MARCH 2013 Profit for the year 22,179 21,512 16,776 Other comprehensive income/(loss) Items that will not be reclassified to profit or loss: Actuarial gains/(losses) on post- employment benefit obligations (47) 68 (211) Tax on items that will not be reclassified to profit or loss 16 (20) 68 Total items that will not be reclassified to profit or loss (31) 48 (143) Items that may be reclassified subsequently to profit or loss: Changes in fair value of available for sale financial instruments 1,429 40 34 Foreign currency translation adjustments (196) 554 197 Effective portion of changes in fair value of cash flow hedges, net 99 (1,650) 1,697 Tax on items that may be reclassified subsequently to profit or loss (96) 64 (741) Total items that may be reclassified subsequently to profit or loss 1,236 (992) 1,187 Other comprehensive income/(loss) for the year, net of tax 1,205 (944) 1,044 Total comprehensive income for the year 23,384 20,568 17,820 Attributable to: Equity holders of the Company 23,384 20,567 17,822 Non-controlling interest - 1 (2) Total comprehensive income for the year 23,384 20,568 17,820 223
Page 1 and 2:
ANNUAL REPORT 2014-15 Good Health C
Page 3 and 4:
Our Brand We are in the business of
Page 5 and 6:
Corporate Overview Annual Report 20
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Statutory Reports • Business Resp
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Statutory Reports • Management Di
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Statutory Reports • Corporate Gov
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Statutory Reports • Additional Sh
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Statutory Reports • Board’s Rep
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Standalone Financial Statements Ann
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Consolidated Financial Statements A
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174: Consolidated Financial Statements A
Page 223: Consolidated Financial Statements A
Page 227 and 228: Notice Annual Report 2014 - 15 NOTI
Page 229 and 230: E-Voting Annual Report 2014 - 15 IN
Page 231: Dr. Reddy’s Laboratories Limited
Page 235 and 236: The future belongs, not to those wh
show all

Good Health Can’t Wait.

Create successful ePaper yourself

Delete template?

Save as template?